Literature DB >> 15121629

Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine.

Héctor J Lacassie1, Alfredo M Germain, Gloria Valdés, M Soledad Fernández, Francisco Allamand, Héctor López.   

Abstract

BACKGROUND: Eisenmenger syndrome in pregnancy may be a life-threatening disease despite recent additions to the treatment options. CASE: We present a woman with severe pulmonary hypertension due to Eisenmenger syndrome treated during pregnancy and delivery and postpartum with L-arginine and sildenafil to enhance the nitric oxide pathway. This combination was associated with significant improvement in the mother's clinical and hemodynamic condition and fetal well-being.
CONCLUSION: The concomitant use of sildenafil and L-arginine for the management of pulmonary hypertension in pregnancy, combined with multidisciplinary care, permitted a good outcome for the mother and her infant.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121629     DOI: 10.1097/01.AOG.0000125148.82698.65

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  18 in total

1.  Cardiοvascular diseases in pregnancy.

Authors:  Dimitrios Godosis; Spyridon Komaitis; Konstantinos Tziomalos; Maria Baltatzi; Georgios Ntaios; Christos G Savopoulos; Apostolos I Hatzitolios
Journal:  Am J Cardiovasc Dis       Date:  2012-05-15

2.  Successful pregnancy outcome with eisenmenger syndrome.

Authors:  Partha Mukhopadhyav; Popli Bhattacharya; Nilofur Begum
Journal:  J Obstet Gynaecol India       Date:  2012-01-24

3.  Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects.

Authors:  Puja K Mehta; Leo Simpson; Eva K Lee; Teresa A Lyle; Michael E McConnell; Wendy M Book
Journal:  Tex Heart Inst J       Date:  2008

4.  Pregnancy outcomes in patients with severe pulmonary hypertension and Eisenmenger syndrome treated with sildenafil monotherapy.

Authors:  Reinalyn S Cartago; Pichy Ann Alan; Jubert Benedicto
Journal:  Obstet Med       Date:  2014-01-10

Review 5.  Dietary interventions for fetal growth restriction - therapeutic potential of dietary nitrate supplementation in pregnancy.

Authors:  Elizabeth Cottrell; Teresa Tropea; Laura Ormesher; Susan Greenwood; Mark Wareing; Edward Johnstone; Jenny Myers; Colin Sibley
Journal:  J Physiol       Date:  2017-02-27       Impact factor: 5.182

6.  Sildenafil citrate and uteroplacental perfusion in fetal growth restriction.

Authors:  Marzieh Vahid Dastjerdi; Sayedehafagh Hosseini; Leila Bayani
Journal:  J Res Med Sci       Date:  2012-07       Impact factor: 1.852

Review 7.  From Pre-Clinical Studies to Clinical Trials: Generation of Novel Therapies for Pregnancy Complications.

Authors:  Elizabeth C Cottrell; Colin P Sibley
Journal:  Int J Mol Sci       Date:  2015-06-08       Impact factor: 5.923

8.  Effects and mechanisms of action of sildenafil citrate in human chorionic arteries.

Authors:  Chrisen H Maharaj; Daniel O'Toole; Tadhg Lynch; John Carney; James Jarman; Brendan D Higgins; John J Morrison; John G Laffey
Journal:  Reprod Biol Endocrinol       Date:  2009-04-23       Impact factor: 5.211

9.  Successful pregnancy in pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report.

Authors:  Michael Streit; Rudolf Speich; Manuel Fischler; Silvia Ulrich
Journal:  J Med Case Rep       Date:  2009-06-09

Review 10.  Effect of L-arginine and sildenafil citrate on intrauterine growth restriction fetuses: a meta-analysis.

Authors:  Juncao Chen; Xiaoyuan Gong; Pingyang Chen; Kaiju Luo; Xiuquan Zhang
Journal:  BMC Pregnancy Childbirth       Date:  2016-08-16       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.